DNA degradation and its defects

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 6, 2014, Pages

  Kawane, Kohki ^a   Motani, Kou ^a   Nagata, Shigekazu ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL; CELL NUCLEUS; CYTOSOL; GENE EXPRESSION; HUMAN; HYDROLYSIS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; CYTOSOL; DNA; GENE EXPRESSION; HUMANS; HYDROLYSIS; SIGNAL TRANSDUCTION;

EID: 84903705009     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016394     Document Type: Review

References (108)

1. Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, Ahn J, Gutman D, Barber GN. 2013. STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell 50: 5-15.
2. Ahn J, Gutman D, Saijo S, Barber GN. 2012. STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci 109: 19386-19391.
3. Bass BP, Tanner EA, Mateos San Martín D, Blute T, Kinser RD, Dolph PJ, McCall K. 2009. Cell-autonomous requirement for DNaseII in nonapoptotic cell death. Cell Death Differ 16: 1362-1371.
4. Bassnett S. 2002. Lens organelle degradation. Exp Eye Res 74: 1-6.
5. Bassnett S. 2009. On the mechanism of organelle degradation in the vertebrate lens. Exp Eye Res 88: 133-139.
6. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: Past, current and future impact on biomedicine. Nat Rev Drug Discov 6: 975-990.
7. Boulares AH, Zoltoski AJ, Yakovlev A, Xu M, Smulson ME. 2001. Roles of DNA fragmentation factor and poly(ADPribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. J Biol Chem 276: 38185-38192.
8. Casciola-Rosen LA, Anhalt G, Rosen A. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179: 1317-1330.
9. Chasis JA, Mohandas N. 2008. Erythroblastic islands: Niches for erythropoiesis. Blood 112: 470-478.
10. Crow Y, Rehwinkel J. 2009. Aicardi-Goutières syndrome and related phenotypes: Linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18: R130-R136.
11. Desmet CJ, Ishii KJ. 2012. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 12: 479-491.
12. Dix MM, Simon GM, Cravatt BF. 2008. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134: 679-691.
13. Eckhart L, Lippens S, Tschachler E, Declercq W. 2013. Cell death by cornification. Biochim Biophys Acta 1833: 3471-3480.
14. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
15. Evans CJ, Aguilera RJ. 2003. DNase II: Genes, enzymes and function. Gene 322: 1-15.
16. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216.
17. Fernandes-Alnemri T, Yu J-W, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, et al. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11: 385-393.
18. Fullwood MJ, Lee J, Lin L, Li G, Huss M, Ng P, Sung W-K, Shenolikar S. 2011. Next-generation sequencing of apoptotic DNA breakpoints reveals association with actively transcribed genes and gene translocations. PLoS ONE 6: e26054.
19. Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M, Barber GN, Stetson DB. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon- dependent autoimmune disease. Immunity 36: 120-131.
20. Gao D, Wu J, Wu Y-T, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903-906.
21. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501.
22. Gómez-Benito M, Balsas P, Carvajal-Vergara X, Pandiella A, Anel A, Marzo I, Naval J. 2007. Mechanism of apoptosis induced by IFN-a in human myeloma cells: Role of Jak1 and Bim and potentiation by rapamycin. Cell Signal 19: 844-854.
23. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187.
24. Höss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T. 1999. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J 18: 3868-3875.
25. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
26. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461: 788-792.
27. Jacobson MD, Weil M, Raff MC. 1997. Programmed cell death in animal development. Cell 88: 347-354.
28. Jain MK, Zoellner C. 2010. Role of ribavirin in HCV treatment response: Now and in the future. Expert Opin Pharmacother 11: 673-683.
29. Jog NR, Frisoni L, Shi Q, Monestier M, Hernandez S, Craft J, Prak ETL, Caricchio R. 2012. Caspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens. Arthritis Rheum 64: 1247-1256.
30. Kawane K, Fukuyama H, Kondoh G, Takeda J, Ohsawa Y, Uchiyama Y, Nagata S. 2001. Requirement ofDNase II for definitive erythropoiesis in the mouse fetal liver. Science 292: 1546-1549.
31. Kawane K, Fukuyama H, Yoshida H, Nagase H, Ohsawa Y, Uchiyama Y, Okada K, Iida T, Nagata S. 2003. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol 4: 138-144.
32. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, Yoshikawa H, Nagata S. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998-1002.
33. Kawane K, Tanaka H, Kitahara Y, Shimaoka S, Nagata S. 2010. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc Natl Acad Sci 107: 19432-19437.
34. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G. 1991. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 10: 4025-4031.
35. Kinchen JM, Ravichandran KS. 2007. Journey to the grave: Signaling events regulating removal of apoptotic cells. J Cell Sci 120: 2143-2149.
36. Kitano M, Nakaya M, Nakamura T, Nagata S, Matsuda M. 2008. Imaging of Rab5 activity identifies essential regulators for phagosome maturation. Nature 453: 241-245.
37. Krieser R, MacLea K, Longnecker D, Fields J, Fiering S, Eastman A. 2002. Deoxyribonuclease IIa is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality. Cell Death Differ 9: 956-962.
38. Leventis PA, Grinstein S. 2010. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39: 407-427.
39. Li LY, Luo X, Wang X. 2001. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99.
40. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341: 1390-1394.
41. Liu X, Zou H, Slaughter C, Wang X. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184.
42. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. 2008. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134: 866-876.
43. McAvoy JW, Chamberlain CG, de Iongh RU, Hales AM, Lovicu FJ. 1999. Lens development. Eye 13: 425-437.
44. McDermott-Roe C, Ye J, Ahmed R, Sun X-M, Serafín A, Ware J, Bottolo L, Muckett P, Cañas X, Zhang J, et al. 2011. Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature 478: 114-118.
45. McGrath K, Kingsley P, Koniski A, Porter R, Bushnell T, Palis J. 2008. Enucleation of primitive erythroid cells generates a transient population of "pyrenocytes" in the mammalian fetus. Blood 111: 2409-2417.
46. McIlroy D, Tanaka M, Sakahira H, Fukuyama H, Suzuki M, Yamamura K, Ohsawa Y, Uchiyama Y, Nagata S. 2000. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev 14: 549-558.
47. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
48. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450: 435-439.
49. Mizuta R, Mizuta M, Araki S, Suzuki K, Ebara S, Furukawa Y, Shiokawa D, Tanuma S, Kitamura D. 2009. DNase gdependent and -independent apoptotic DNA fragmentations in Ramos Burkitt's lymphoma cell line. Biomed Res 30: 165-170.
50. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE. 2004. Gene-targeted mice lacking the Trex1 (DNase III) 30!50 DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 24: 6719-6727.
51. Mukae N, Enari M, Sakahira H, Fukuda Y, Inazawa J, Toh H, Nagata S. 1998. Molecular cloning and characterization of human caspase-activated DNase. Proc Natl Acad Sci 95: 9123-9128.
52. Mukae N, Yokoyama H, Yokokura T, Sakoyama Y, Nagata S. 2002. Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation. Genes Dev 16: 2662-2671.
53. Nagase H, Fukuyama H, Tanaka M, Kawane K, Nagata S. 2003.Mutually regulated expression of caspase-activated DNase and its inhibitor for apoptotic DNA fragmentation. Cell Death Differ 10: 142-143.
54. Nagata S. 1997. Apoptosis by death factor. Cell 88: 355-365.
55. Nagata S. 2005. DNA degradation in development and programmed cell death. Annu Rev Immunol 23: 853-875.
56. Nakahara M, Nagasaka A, Koike M, Uchida K, Kawane K, Uchiyama Y, Nagata S. 2007. Degradation of nuclear DNA by DNase II-like acid DNase in cortical fiber cells of mouse eye lens. FEBS J 274: 3055-3064.
57. Nakaya M, Kitano M, Matsuda M, Nagata S. 2008. Spatiotemporal activation of Rac1 for engulfment of apoptotic cells. Proc Natl Acad Sci 105: 9198-9203.
58. Napirei M, Wulf S, Mannherz H. 2004. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum 50: 1873-1883.
59. Nishimoto S, Kawane K, Watanabe-Fukunaga R, Fukuyama H, Ohsawa Y, Uchiyama Y, Hashida N, Ohguro N, Tano Y, Morimoto T, et al. 2003.Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature 424: 1071-1074.
60. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, et al. 2012. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485: 251-255.
61. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med 202: 1333-1339.
62. Okabe Y, Kawane K, Nagata S. 2008. IFN regulatory factor (IRF) 3/7-dependent and -independent gene induction by mammalian DNA that escapes degradation. Eur J Immunol 38: 3150-3158.
63. Okabe Y, Sano T, Nagata S. 2009. Regulation of the innate immune response by threonine-phosphatase of eyes absent. Nature 460: 520-524.
64. O'Neill LAJ. 2013. Immunology. Sensing the dark side of DNA. Science 339: 763-764.
65. Ostertag EM, Kazazian HH. 2001. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35: 501-538.
66. Palis J. 2008. Ontogeny of erythropoiesis. Curr Opin Hematol 15: 155-161.
67. Paludan SR, Bowie AG. 2013. Immune sensing of DNA. Immunity 38: 870-880.
68. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, Ravichandran KS. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450: 430-434.
69. Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH, Kwon TH, Park RW, Kim IS. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 15: 192-201.
70. Penninger JM, Kroemer G. 2003. Mitochondria, AIF and caspases-Rivaling for cell death execution. Nat Cell Biol 5: 97-99.
71. Prak ET, Kazazian HH. 2000. Mobile elements and the human genome. Nat Rev Genet 1: 134-144.
72. Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11: 395-402.
73. Rekvig OP, Mortensen ES. 2012. Immunity and autoimmunity to dsDNAand chromatin-The role of immunogenic DNA-binding proteins and nuclease deficiencies. Autoimmunity 45: 588-592.
74. Rhodes MM, Kopsombut P, Bondurant MC, Price JO, Koury MJ. 2008. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 111: 1700-1708.
75. Ronald PC, Beutler B. 2010. Plant and animal sensors of conserved microbial signatures. Science 330: 1061-1064.
76. Sakahira H, Nagata S. 2002. Co-translational folding of caspase- activated DNase with Hsp70, Hsp40 and inhibitor of caspase-activatedDNase. J Biol Chem 277: 3364-3370.
77. Sakahira H, Enari M, Nagata S. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99.
78. Sakahira H, Iwamatsu A, Nagata S. 2000. Specific chaperone- like activity of inhibitor of caspase-activated DNase for caspase-activated DNase. J Biol Chem 275: 8091-8096.
79. Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, Gabriel A, Swergold GD, Kazazian HH. 1997. Many human L1 elements are capable of retrotransposition. Nat Genet 16: 37-43.
80. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211.
81. Scott D, Wolfe F, Huizinga T. 2010. Rheumatoid arthritis. Lancet 376: 1094-1108.
82. Shiokawa D, Tanuma S. 1999. DLAD, a novel mammalian divalent cation-independent endonuclease with homology to DNase II. Nucleic Acids Res 27: 4083-4089.
83. Stetson DB, Ko JS, Heidmann T, Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
84. Strasser A, Jost PJ, Nagata S. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
85. Su DM, Wang J, Lin Q, Cooper MD, Watanabe T. 1997. Interferons a/b inhibit IL-7-induced proliferation of CD42 CD82 CD32 CD44{thorn} CD25{thorn} thymocytes, but do not inhibit that of CD42 CD82 CD32 CD442 CD252 thymocytes. Immunology 90: 543-549.
86. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013.CyclicGMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786-791.
87. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, et al. 2000. Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580.
88. Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. 2013. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 341: 403-406.
89. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
90. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal 5: ra20-ra20.
91. Tang HL, Tang HM, Mak KH, Hu S, Wang SS, Wong KM, Wong CST, Wu HY, Law HT, Liu K, et al. 2012. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell 23: 2240-2252.
92. Terman A, Kurz T, Gustafsson B, Brunk UT. 2006. Lysosomal labilization. IUBMB Life 58: 531-539.
93. Toda S, Hanayama R, Nagata S. 2012. Two-step engulfment of apoptotic cells. Mol Cell Biol 32: 118-125.
94. Vastert SJ, Kuis W, Grom AA. 2009. Systemic JIA: New developments in the understanding of the pathophysiology and therapy. Best Pract Res Clin Rheumatol 23: 655-664.
95. von Figura K, Hasilik A. 1986. Lysosomal enzymes and their receptors. Annu Rev Biochem 55: 167-193.
96. Woo E-J, Kim Y-G, Kim M-S, Han W-D, Shin S, Robinson H, Park S-Y, Oh B-H. 2004. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell 14: 531-539.
97. Wu YC, Stanfield GM, Horvitz HR. 2000. NUC-1, a Caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis. Genes Dev 14: 536-548.
98. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. CyclicGMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339: 826-830.
99. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
100. Xiao TS, Fitzgerald KA. 2013. The cGAS-STING pathway for DNA sensing. Mol Cell 51: 135-139.
101. Xiong W, Chen Y, Wang H, Wu H, Lu Q, Han D. 2008. Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phagocytic function of Sertoli cells. Reproduction 135: 77-87.
102. Yan B, Wang H, Peng Y, Hu Y, Wang H, Zhang X, Chen Q, Bedford JS, Dewhirst MW, Li C-Y. 2006. A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc Natl Acad Sci 103: 1504-1509.
103. Yan N, Regalado-Magdos A, Stiggelbout B, Lee-Kirsch M, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 11: 1005-1013.
104. Yang HW, Chen YZ, Piao HY, Takita J, Soeda E, Hayashi Y. 2001. DNA fragmentation factor 45 (DFF45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line. Neoplasia 3: 165-169.
105. Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28: 313-314.
106. Yoshida H, Kawane K, Koike M, Mori Y, Uchiyama Y, Nagata S. 2005a. hosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437: 754-758.
107. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S. 2005b. Lethal anemia caused by interferon-b produced in mouse embryos carrying undigestedDNA. Nat Immunol 6: 49-56.
108. Zhang J, Liu X, Scherer DC, van Kaer L, Wang X, Xu M. 1998. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc Natl Acad Sci 95: 12480-12485.